Source:http://linkedlifedata.com/resource/pubmed/id/19094948
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9645
|
pubmed:dateCreated |
2008-12-19
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1474-547X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
4
|
pubmed:volume |
372
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1218-9
|
pubmed:meshHeading |
pubmed-meshheading:19094948-Benzazepines,
pubmed-meshheading:19094948-Humans,
pubmed-meshheading:19094948-Mental Disorders,
pubmed-meshheading:19094948-Patient Selection,
pubmed-meshheading:19094948-Quinoxalines,
pubmed-meshheading:19094948-Randomized Controlled Trials as Topic,
pubmed-meshheading:19094948-Risk Factors,
pubmed-meshheading:19094948-Smoking Cessation
|
pubmed:year |
2008
|
pubmed:articleTitle |
Varenicline and smokers with mental illnesses.
|
pubmed:publicationType |
Letter
|